Biologics lift for UK
April 22, 2014Manufacturing and Production, Sales and Marketing Cameron, UK, biologics, darlington, nbmc
Work has begun on a key new £38 million centre in Central Park, Darlington, which should increase the biologics capability …
arGEN-X appoints Evotec chief executive
April 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evotec, arGEN-X, lanthaler
Belgium-based clinical stage human therapeutic antibody firm arGEN-X has appointed Dr Werner Lanthaler to its supervisory board.
 Lanthaler is currently …
Novartis ponders Horsham site future
April 14, 2014Research and Development, Sales and Marketing Horsham, Novartis, Osborne, PharmaVentures, medcity, research, site
Novartis has hired specialist consultancy firm PharmaVentures to help it decide how to re-use it former Horsham site. This comes …
GSK bribery controversy spreads to Poland
April 14, 2014Medical Communications, Sales and Marketing China, FDA, GSK, Witty, bribery, cctv, iraq
Poland has become the latest country in a string of bribery claims to hit GSK as it faces legal action …
How can ‘innovation’ be defined?
April 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, NHS, UK, eric low, innovation, myeloma
Innovation has been and continues to be an important topic of discussion for a number of different stakeholders and disciplines …
EMA to conduct major review into testosterone drugs
April 14, 2014Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone
The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …
Roche/Novartis offices raided over anti-competitive activities
April 11, 2014Sales and Marketing Lucentis, Novartis, Roche, SHIP Cluster, avastin, wet AMD
French competition authorities are investigating Roche and Novartis in connection with their marketing of Lucentis for wet age-related macular degeneration …
Pfizer’s Jonathan Emms becomes new ABPI president
April 11, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, Pfizer, jonathan emms
Jonathan Emms, UK managing director of Pfizer, has taken up his appointment as president of the ABPI, after his election …
NICE to look again at Tamiflu after data saga
April 11, 2014Medical Communications, Sales and Marketing Jeremy Hunt, Roche, Tamiflu
The UK government has asked NICE to review its guidance for Roche’s troubled pandemic flu medicine Tamiflu after a new …
Merck gets hep C boost as competition ramps up
April 11, 2014Research and Development, Sales and Marketing Merck, daclatasvir, hep C, sovaldi
Merck has released promising data from a trial which uses two of its investigational compounds to treat patients with hepatitis …
Herceptin faces UK competition within months
April 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biocon, Herceptin, Hospira, Perjeta, breast cancer
Roche’s blockbuster breast cancer drug Herceptin may soon be under threat from copycat treatments after a court in the UK …
Regulatory woes eclipse Sun Pharma deal
April 10, 2014Manufacturing and Production, Sales and Marketing FDA, India, Ranbaxy, Sun Pharma
The $4 billion merger between Indian generic firms Sun Pharma and Ranbaxy has been soured by reports that the deal …
Tamiflu stockpiling ‘unjustifiable’ and wasted £424m
April 10, 2014Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials
Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …
DIA appoints Dr Haijun Dong as MD for DIA China
April 10, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia
Biopharmaceutical executive Dr Haijun (Lou) Dong has been named as the new managing director for DIA China. “Dr Dong brings …
Boehringer: ‘devil in detail’ on new drug pricing policy
April 10, 2014Medical Communications, Sales and Marketing Boehringer, PPRS, VBP, Zinta Krumins, alltrials, vba
Zinta Krumins, the newly-appointed managing director of Boehringer Ingelheim UK and Ireland, has warned that the ‘devil is in the …
NHS needs to understand drug costs better, says ABPI
April 10, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, AGNSS, Deepak Khanna, NICE, Stephen Whitehead, Tarceva, soliris
The UK healthcare system is at risk of failing to adopt new, personalised medicines and must be willing to pay …
Hugo Mendoza takes on new role at Masters Speciality Pharma
April 9, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing t Masters Speciality Pharma
Masters Speciality Pharma has appointed Hugo Mendoza as its new business development director for the Caribbean and Central America territories. …
Former health minister tells NHS to embrace technology
April 9, 2014Medical Communications, Sales and Marketing Jeremy Hunt, autism, brain in hand, google, paperless, telehealth
The Labour MP and former health minister Ben Bradshaw has urged the National Health Service to do more when it …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
